Search research articles
Contact Us
Filters
Showing results (111-120 of 152) with videos related to
Page
of 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 8, 2010
Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205
Philip A Philip, Jacqueline Benedetti, Christopher L Corless, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 19, 2014
Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial
Christopher L Corless, Karla V Ballman, Cristina R Antonescu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2008
Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group
Michael C Heinrich, Kouros Owzar, Christopher L Corless, et al.
JAMA Ophthalmology
|
September 19, 2014
Age-related cataract in men in the selenium and vitamin e cancer prevention trial eye endpoints study: a randomized clinical trial
William G Christen, Robert J Glynn, J Michael Gaziano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2015
Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation
Pierre Bohanes, Cathryn J Rankin, Charles D Blanke, et al.
JAMA Oncology
|
December 16, 2016
Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy: SWOG S1115 Study Randomized Clinical Trial
Vincent Chung, Shannon McDonough, Philip A Philip, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2019
Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance)
Chen Yuan, Kaori Sato, Bruce W Hollis, et al.
Lancet (London, England)
|
March 24, 2009
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
Ronald P Dematteo, Karla V Ballman, Cristina R Antonescu, et al.
NPJ Precision Oncology
|
January 24, 2025
Dual anti-CTLA-4 and anti-PD-1 blockade in metastatic basal cell carcinoma
Sandip P Patel, Eleanor Cano-Linson, Young Kwang Chae, et al.
Cancer Communications (London, England)
|
May 22, 2025
A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: durable responses and delayed pseudoprogression in small cell carcinoma of the ovary, hypercalcemic type cohort
Young Kwang Chae, Megan Othus, Sandip Pravin Patel, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 152) with videos related to
Sort By:
Page
of 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 8, 2010
Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205
Philip A Philip, Jacqueline Benedetti, Christopher L Corless, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 19, 2014
Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial
Christopher L Corless, Karla V Ballman, Cristina R Antonescu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2008
Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group
Michael C Heinrich, Kouros Owzar, Christopher L Corless, et al.
JAMA Ophthalmology
|
September 19, 2014
Age-related cataract in men in the selenium and vitamin e cancer prevention trial eye endpoints study: a randomized clinical trial
William G Christen, Robert J Glynn, J Michael Gaziano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2015
Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation
Pierre Bohanes, Cathryn J Rankin, Charles D Blanke, et al.
JAMA Oncology
|
December 16, 2016
Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy: SWOG S1115 Study Randomized Clinical Trial
Vincent Chung, Shannon McDonough, Philip A Philip, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2019
Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance)
Chen Yuan, Kaori Sato, Bruce W Hollis, et al.
Lancet (London, England)
|
March 24, 2009
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
Ronald P Dematteo, Karla V Ballman, Cristina R Antonescu, et al.
NPJ Precision Oncology
|
January 24, 2025
Dual anti-CTLA-4 and anti-PD-1 blockade in metastatic basal cell carcinoma
Sandip P Patel, Eleanor Cano-Linson, Young Kwang Chae, et al.
Cancer Communications (London, England)
|
May 22, 2025
A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: durable responses and delayed pseudoprogression in small cell carcinoma of the ovary, hypercalcemic type cohort
Young Kwang Chae, Megan Othus, Sandip Pravin Patel, et al.
Page
of 16